Peptide Labeling for Aspartate Isoaspartate Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting isoaspartate in peptides are complex, time-consuming, or inefficient, particularly affecting the shelf-life and activity of protein-bound pharmaceuticals, and are challenged by factors like pH and protein structure.
Innovation Solution
A method involving chemical derivatization using a peptide labeling reagent like 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) to label aspartate/isoaspartate residues, which undergo rearrangement at different rates in the gas phase, facilitating detection through mass spectrometry analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If mass spectrometric methods like ETD, ECD, or 18O labelling are used to detect isoAsp, then detection precision is improved, but device complexity and time requirements increase
Solution Approach 1:
The invention changes the detection parameter from complex fragmentation patterns (ETD/ECD) or isotopic labeling (18O) to a simple mass shift detection. By using a labeling reagent that adds a specific mass tag to Asp/isoAsp residues, the detection is simplified to measuring the presence or absence of this mass tag, reducing device complexity while maintaining precision
Solution Approach 2:
The invention extracts the detection target from complex protein structures to isolated Asp/isoAsp residues that have been chemically labeled. By separating the detection of these specific labeled residues from the complexity of the whole protein analysis, the method achieves high precision with simpler equipment
2Measurement precision
If enzymatic fluorescence-based assays are used to detect isoAsp, then detection sensitivity is improved, but time requirements increase
Solution Approach 1:
The invention performs preliminary chemical labeling of Asp/isoAsp residues with a mass-tagging reagent before detection. This preliminary action converts the detection task into a simple mass measurement that can be rapidly performed by mass spectrometry, eliminating the time-consuming enzymatic steps while maintaining sensitivity through the specific mass tag detection
3Measurement precision
If HPLC methods are used to separate Asp/isoAsp containing peptides, then separation capability is improved, but reliance on secondary structure changes limits applicability
Solution Approach 1:
The invention changes the detection parameter from secondary structure-based separation (HPLC) to chemical labeling-based mass detection. By labeling Asp/isoAsp residues with a mass tag and detecting the resulting mass shift, the method becomes applicable to all peptides containing these residues regardless of their secondary structure, greatly improving versatility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a fast, inexpensive, and accessible method for determining the presence of isoaspartate in peptides, improving the analysis of protein-bound drugs and understanding its link to diseases like Alzheimer's.
Implementation Method 1
ionizing the labeled peptide, wherein the ionizing causes the label to undergo rearrangement in a gas phase at a higher rate if the label is bound to an aspartate residue as compared to if the label is bound to an isoaspartate residue
Implementation Method 2
performing a mass spectrometry analysis to detect the rearrangement of the label, thereby determining whether the peptide comprises aspartate or isoaspartate
Data Source
AI summary
The invention generally relates to methods for determining whether a peptide includes aspartate or isoaspartate. In certain aspects, methods of the invention involve binding an aspartate/isoaspartate residue in a peptide with a label to produce a labeled peptide. The labeled peptide is then ionized. The ionizing process causes the label to undergo rearrangement in a gas phase at a higher rate if the label is bound to the aspartate residue as compared to if the label is bound to the isoaspartate residue. The methods of the invention then involve performing a mass spectrometry analysis to detect the rearrangement of the label, thereby determining whether the peptide includes aspartate or isoaspartate.